Key result
Loss of myosin VI in mice impairs PKA signaling and alters hindlimb skeletal muscle metabolism, leading to an increased muscle to body mass ratio and decreased fiber size, particularly in newborns.
Why the study?
To elucidate the potential role of myosin VI in PKA signaling in hindlimb muscle function, based on its interaction with AKAP9 and phosphorylation by PKA.
Does lack of Myosin VI affect cAMP/PKA signaling and muscle metabolism in hindlimb skeletal muscle of mice?
Does lack of Myosin VI affect cAMP/PKA signaling and muscle metabolism in hindlimb skeletal muscle of mice?
Lack of Myosin VI impairs PKA signaling and alters skeletal muscle metabolism, particularly in newborn mice.
MVI-AKAP9 interaction may modulate PKA signaling in striated muscle; leaves open its relevance to cardiovascular myogenesis pending functional validation.
Myosin VI (MVI) is a unique unconventional myosin ubiquitously expressed in metazoans. Its diverse cellular functions are mediated by interactions with a number of binding partners present in multi-protein complexes. MVI is proposed to play important roles in muscle function and myogenesis. Previously, we showed that MVI is present in striated muscles and myogenic cells, and MVI interacts with A-kinase anchoring protein 9 (AKAP9), a scaffold for PKA and its regulatory proteins. Since PKA directly phosphorylates the MVI cargo binding domain, we hypothesized that the cellular effects of MVI are mediated by the cAMP/PKA signaling pathway, known to play important roles in skeletal muscle metabolism and myogenesis. To elucidate the potential role of MVI in PKA signaling in hindlimb muscle function, we used mice lacking MVI (Snell’s waltzer, SV), considered as natural MVI knockouts, and heterozygous littermates. We used muscles isolated from newborn (P0) as well as 3- and 12-month-old adult mice. We observed a significant increase in the muscle to body mass ratio, which was most evident for the soleus muscle, as well as changes in fiber size, indicating alterations in muscle metabolism. These observations were accompanied by age-dependent changes in the activity of PKA and cAMP/PKA-dependent transcriptional factor (CREB). Additionally, the levels of adenylate cyclase isoforms and phosphodiesterase (PDE4) were age-dependent. Also, cAMP levels were decreased in the muscle of P0 mice. Together, these observations indicate that lack of MVI impairs PKA signaling and results in the observed alterations in the SV muscle metabolism, in particular in newborn mice.
No takes yet. Share an insight, caveat, or question.
Lehka et al. (2022) studied Myosin VI deficiency. Myosin VI knockout vs. Heterozygous littermates was evaluated on Muscle to body mass ratio and cAMP/PKA signaling activity. Loss of myosin VI in mice impairs PKA signaling and alters hindlimb skeletal muscle metabolism, leading to an increased muscle to body mass ratio and decreased fiber size, particularly in newborns.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: